(Q37993347)

26 August 2017

Mesangial cell biology (English)

1 reference

26 August 2017

1 reference

1 reference

Hanna E Abboud

1

1 reference

PubMed ID

22414873

26 August 2017

language of work or name

English

0 references

publication date

5 March 2012

1 reference

Experimental Cell Research

26 August 2017

1 reference

26 August 2017

318

1 reference

26 August 2017

9

1 reference

26 August 2017

979-985

1 reference

The mesangial cell revisited: no cell is an island

26 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Diabetic nephropathy: mechanisms of renal disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Phenotypic transitions and fibrosis in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Mesangial pathology in glomerular disease: targets for therapeutic intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Ion channels in mesangial cells: function, malfunction, or fiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Development of the renal glomerulus: good neighbors and good fences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

How do mesangial and endothelial cells form the glomerular tuft?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Endothelin-1 increases collagen accumulation in renal mesangial cells by stimulating a chemokine and cytokine autocrine signaling loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Human matrix metalloproteinases: characteristics and pathologic role in altering mesangial homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

The aging kidney phenotype and systemically derived stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Changes in extracellular matrix composition regulate cyclooxygenase-2 expression in human mesangial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

A new look at platelet-derived growth factor in renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Renal fibrosis: new insights into the pathogenesis and therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Proteinuria in diabetic kidney disease: a mechanistic viewpoint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Hyperglycemia and glucosamine-induced mesangial cell cycle arrest and hypertrophy: Common or independent mechanisms?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Mechanical forces in diabetic kidney disease: a trigger for impaired glucose metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Pathogenetic mechanisms of diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

New paradigms in cell death in human diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

7 January 2021

The sweet side of HIF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

SOX9 protein induces a chondrogenic phenotype of mesangial cells and contributes to advanced diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

NFkappaB promotes inflammation, coagulation, and fibrosis in the aging glomerulus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

ID1 inhibits USF2 and blocks TGF-β-induced apoptosis in mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

SREBP-1 activation by glucose mediates TGF-β upregulation in mesangial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

In vivo delivery of Gremlin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by recovering bone morphogenetic protein-7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Gremlin: an example of the re-emergence of developmental programmes in diabetic nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Suppressors of cytokine signaling abrogate diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

AMP-activated protein kinase inhibits transforming growth factor-beta-induced Smad3-dependent transcription and myofibroblast transdifferentiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Role of the USF1 transcription factor in diabetic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Nutrient sensing, autophagy, and diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

GLUT1 enhances mTOR activity independently of TSC2 and AMPK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

High glucose-induced hypertrophy of mesangial cells is reversed by connexin43 overexpression via PTEN/Akt/mTOR signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Rapamycin induces the TGFbeta1/Smad signaling cascade in renal mesangial cells upstream of mTOR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Oxidative stress as a major culprit in kidney disease in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Knockdown of thioredoxin interacting protein attenuates high glucose-induced apoptosis and activation of ASK1 in mouse mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Subcellular localization of Nox4 and regulation in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Modulation of Nrf2 expression alters high glucose-induced oxidative stress and antioxidant gene expression in mouse mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Prevention of diabetic nephropathy in Ins2(+/)⁻(AkitaJ) mice by the mitochondria-targeted therapy MitoQ.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Canonical transient receptor potential channels in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Targeting kidney mesangium by nanoparticles of defined size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Cutting edge: Calcium/Calmodulin-dependent protein kinase type IV is essential for mesangial cell proliferation and lupus nephritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

Genes expressed by the kidney, but not by bone marrow-derived cells, underlie the genetic predisposition to progressive glomerulosclerosis after mesangial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.02.025

10.1016/J.YEXCR.2012.02.025

7 January 2021

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22414873